Drug indexes sluggish; Teva climbs

The drug-sector indexes are relatively flat in early action, while shares of Teva gain on a positive study for its new MS drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.